Replimune Group Insider Reports Securities Ownership Change
Ticker: REPL · Form: 4 · Filed: 2026-04-07T21:10:52-04:00
Sentiment: neutral
Topics: insider-transaction, ownership-change
TL;DR
Philip Astley-Sparke updated his Replimune stock ownership on 4/1/26.
AI Summary
On April 1, 2026, Philip Astley-Sparke, a reporting person associated with Replimune Group, Inc., reported a change in beneficial ownership of securities. The filing details transactions related to the company's stock, with specific numbers of shares and transaction types not fully detailed in this excerpt.
Why It Matters
This filing indicates potential shifts in insider holdings, which can sometimes signal confidence or concerns from key individuals within Replimune Group, Inc.
Risk Assessment
Risk Level: low — Form 4 filings typically report routine changes in beneficial ownership and do not inherently signal significant risk.
Key Numbers
- 2026-04-01 — Period of Report (Date of reported ownership change)
- 2026-04-07 — Filing Date (Date the report was officially filed with the SEC)
Key Players & Entities
- Philip Astley-Sparke (person) — Reporting person
- Replimune Group, Inc. (company) — Issuer
- 0001737953 (company) — Issuer CIK
- 0001376491 (person) — Reporting person CIK
FAQ
Who is the reporting person in this filing?
The reporting person is Philip Astley-Sparke.
What company is this filing related to?
This filing is related to Replimune Group, Inc.
What is the period of report for this filing?
The period of report is April 1, 2026.
When was this Form 4 filing accepted by the SEC?
This Form 4 filing was accepted on April 7, 2026.
What is the CIK for Replimune Group, Inc.?
The CIK for Replimune Group, Inc. is 0001737953.
From the Filing
EDGAR Filing Documents for 0001104659-26-040577 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 4 - Statement of changes in beneficial ownership of securities: SEC Accession No. 0001104659-26-040577 Filing Date 2026-04-07 Accepted 2026-04-07 21:10:52 Documents 1 Period of Report 2026-04-01 Document Format Files Seq Description Document Type Size 1 OWNERSHIP DOCUMENT tm2611350-14_4seq1.html 4 1 OWNERSHIP DOCUMENT tm2611350-14_4seq1.xml 4 6321 Complete submission text file 0001104659-26-040577.txt 7755 Mailing Address C/O BIOVEX GROUP, INC. 34 COMMERCE WAY WOBURN MA 10801 Business Address Astley-Sparke Philip ( Reporting ) CIK : 0001376491 (see all company filings) Type: 4 | Act: 34 | File No.: 001-38596 | Film No.: 26846268 Mailing Address 500 UNICORN PARK WOBURN MA 01801 Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600 Replimune Group, Inc. ( Issuer ) CIK : 0001737953 (see all company filings) EIN. : 822082553 | State of Incorp.: DE | Fiscal Year End: 0331 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)